483,551 Shares in ChronoScale Corporation Common Stock $CHRN Bought by TrinityBridge Ltd

TrinityBridge Ltd bought a new stake in ChronoScale Corporation Common Stock (NASDAQ:CHRN) during the second quarter, according to its most recent filing with the SEC. The firm bought 483,551 shares of the company’s stock, valued at approximately $182,441,000. ChronoScale Corporation Common Stock comprises 4.9% of TrinityBridge Ltd’s holdings, making the stock its 6th biggest holding. TrinityBridge Ltd owned approximately 13.58% of ChronoScale Corporation Common Stock at the end of the most recent reporting period.

Other institutional investors have also recently bought and sold shares of the company. J.Safra Asset Management Corp acquired a new position in ChronoScale Corporation Common Stock during the 2nd quarter worth $105,000. Roble Belko & Company Inc grew its position in shares of ChronoScale Corporation Common Stock by 104.5% in the first quarter. Roble Belko & Company Inc now owns 2,338 shares of the company’s stock valued at $25,000 after purchasing an additional 1,195 shares during the last quarter. Great Lakes Advisors LLC acquired a new stake in shares of ChronoScale Corporation Common Stock in the second quarter valued at about $755,000. Geode Capital Management LLC increased its stake in shares of ChronoScale Corporation Common Stock by 68.9% in the fourth quarter. Geode Capital Management LLC now owns 25,212 shares of the company’s stock worth $218,000 after purchasing an additional 10,281 shares during the period. Finally, Virtu Financial LLC bought a new position in shares of ChronoScale Corporation Common Stock in the third quarter worth about $57,000. Institutional investors own 6.42% of the company’s stock.

ChronoScale Corporation Common Stock Price Performance

NASDAQ CHRN opened at $24.10 on Friday. The stock has a 50-day simple moving average of $21.82 and a 200 day simple moving average of $15.69. ChronoScale Corporation Common Stock has a twelve month low of $3.23 and a twelve month high of $30.00. The stock has a market capitalization of $85.80 million, a PE ratio of -4.48 and a beta of 1.00. The company has a debt-to-equity ratio of 0.25, a quick ratio of 1.03 and a current ratio of 1.55.

ChronoScale Corporation Common Stock (NASDAQ:CHRN) last issued its quarterly earnings results on Tuesday, June 30th. The company reported ($3.89) EPS for the quarter. ChronoScale Corporation Common Stock had a negative return on equity of 197.81% and a negative net margin of 135.66%.The business had revenue of $18.09 million during the quarter. Research analysts anticipate that ChronoScale Corporation Common Stock will post -0.1 EPS for the current year.

ChronoScale Corporation Common Stock Company Profile

Ekso Bionics Holdings, Inc (NASDAQ:EKSO) is a leading developer of wearable bionic exoskeletons designed to enhance human mobility and strength. Headquartered in Richmond, California, the company was founded in 2005 (originally as Berkeley Bionics) and completed its initial public offering in 2014. Its patented robotic systems support both rehabilitation and industrial applications by providing powered, adjustable assistance for a range of movement tasks.

In the medical sector, Ekso Bionics offers externally worn exoskeletons such as the EksoNR and EksoGT, which assist patients recovering from stroke, spinal cord injury or other neurological conditions.